FIND’s Post

🚀 Exciting Growth in the #Insulin #Pump #Market! 🌟 The insulin pump market is experiencing significant growth, driven by advancements in technology, rising prevalence of diabetes, and increasing patient awareness about diabetes management. 📈 🔹 Opportunities for Innovation: There is tremendous potential for further innovation in this market. Companies investing in research and development to enhance pump functionality, connectivity, and user experience are set to lead the way. #DiabetesCare #InsulinPumps #MedicalInnovation #HealthcareTechnology #PatientCare #DiabetesManagement #Innovation

Now that continuous glucose monitors (CGMs) don't require a prescription in the U.S., your patients are going to show up with questions about them and their data! 📉 What you want to say is, "Of course I can give you some feedback on that." However, interpreting CGM data is not as easy as you think.  Grab this free guide to learn more about using it with your clients. Of course, the freebie puts you on a newsletter list. But THIS mailing list tags you for a newsletter from me just once every 1-3 months, where we focus exclusively on industry news, interesting research on CGM and blood sugar, and events I have coming up.  https://lnkd.in/gypDgNJ5 

Roche has recently secured the CE mark, enabling it to enter the European CGM market and challenge Abbott and Dexcom. The CGM has AI that can predict glucose levels up to two hours in advance. There is a general consensus among Wall Street analysts that this new device is unlikely to pose a significant competitive threat to Dexcom and Abbott, and have expressed concerns about the need for initial calibration as a potential uptake barrier. However, Roche believes this unique feature sets them apart from its well-established incumbents as the glucose level prediction can help patients reduce stress and fear of hypoglycemia. We will soon find out how well this pitch resonates with diabetes patients in Europe. #Roche #CEMark #Healthcare #GlucoseMonitor #Acccheck #healthtech #healthcare #diabetescare #medicaldevices #CGM #medtech #medtechinsights #medtechnews #IVD #devicetalks #DiabetesManagement #diabetes #eosintelligence

𝐄𝐮𝐫𝐨𝐩𝐞 𝐈𝐧𝐬𝐮𝐥𝐢𝐧 𝐏𝐮𝐦𝐩𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐 The Europe insulin pumps market size is projected to exhibit a growth rate (CAGR) of 5.13% during 2024-2032. The rising diabetes prevalence, patient-centric healthcare trends, supportive policies, and significant technological advancements and collaborative innovation efforts represent some of the key factors driving the market. 𝐆𝐫𝐚𝐛 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/gRZf_gaX 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬: ● 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐃𝐞𝐦𝐚𝐧𝐝 & 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬: Increased awareness of benefits like fewer injections and better blood sugar control is driving patient interest in insulin pump therapy, leading to market growth. ● 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐫 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐞: Educating patients about insulin pump therapy and its advantages significantly impacts its adoption, with healthcare providers playing a key role. ● 𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐨𝐟 𝐋𝐢𝐟𝐞: The growing emphasis on improving quality of life for diabetics is a positive influence. Insulin pump therapy's flexibility and glycemic control benefits allow for more active lifestyles. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/g8Ef9ymh #europeinsulinmarket #marketresearch #business #marketanalysis #markettrends #researchreport #marketreport #marketforecast #marketgrowth #businessinsights #industryanalysis #marketoutlook #growthprojections #marketstatistics #competitiveanalysis #trendanalysis #marketinsights #imarcgroup

Over 70% of hypertension patients are willing to consider renal denervation (RND) as a hypertension management approach given the high likelihood of meaningful blood pressure drop, and the global RND market value is projected to exceed $2 billion by 2031. The Clarivate Medical Technologies to Watch 2024 report provides a comprehensive predictive analysis of five high-growth medical technology markets poised to generate over $1 billion in value or achieve double-digit growth within the next five years. Discover more about the innovations set to drive significant clinical and market impact despite recent challenges in the medtech sector here: https://lnkd.in/du-v7bD9 #MedicalTechnologiesToWatch #MedicalDevices #Medtech #MedicalTechnology #renaldenervation #hypertension

GLP-1 drugs, including Ozempic, have evolved beyond diabetes care, gaining notoriety for weight loss. Our analytics dive into the impact these drugs have on plan costs and health outcomes. Read more to discover actionable insights as we navigate this healthcare revolution. https://lnkd.in/dndrS957 #GLP1Drugs #HealthAnalytics

According to a new market research report published by Global Market Estimates, the global medical tubing market is projected to grow at a CAGR of 8.5% from 2024 to 2029. The growth of the global medical tubing market is driven by advancements in medical technology and a rise in chronic diseases. Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC https://lnkd.in/dfZCBb4Q #GlobalMedicalTubingMarket #GlobalMarketEstimates #GME

Are you curious about the reasons why HCPs prefer old over new-generation insulins? Connect at srishti@graphenesvc.com to also learn how cost impacts patient insulin compliance and what can be done to improve it. Our comprehensive report, based on an extensive online survey of patients and HCPs across the USA, delves into these critical issues.  This syndicated report is highly relevant for businesses seeking to understand and adapt to the changing landscape of the insulin market in the USA.  #Insulin #GrapheneAI #CoPayPolicy #HealthcareResearch

The focus on diabetes and obesity in clinical research is increasing, driving higher demand for accurate Continuous Glucose Monitoring (CGM) devices. CGM use jumped from 0.4% to 4.1% between 2014 and 2020, highlighting their growing importance in diabetes management. At Woodley Trial Solutions, we're here to supply the CGM devices you need. When choosing a CGM device supplier, consider these 5 key factors: 1️⃣ - Reliable availability   2️⃣ - Supply expertise   3️⃣ - Responsive logistics   4️⃣ - Dedicated support   5️⃣ - Secure data transfer to CRO Our team at Woodley Trial Solutions is ready to support your clinical trial needs. Learn more about our CGM supply capabilities in our client case studies here ⬇️   https://lnkd.in/eUxGTsxV 🔗 Interested? Express your interest here to get started ⬇️   https://lnkd.in/ecD-V6k6 #continuousglucosemonitoring hashtag#cgm hashtag#clinicalresearch hashtag#diabetes hashtag#obesity